Protein Summary
Implicated in endocytosis. May recruit other proteins to membranes with high curvature (By similarity). This gene encodes a member of the endophilin family of Src homology 3 domain-containing proteins. The encoded protein is involved in endocytosis and may also play a role in the cell cycle. Overexpression of this gene may play a role in leukemogenesis, and the encoded protein has been implicated in acute myeloid leukemia as a fusion partner of the myeloid-lymphoid leukemia protein. Pseudogenes of this gene are located on the long arm of chromosomes 11 and 17. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
- ENST00000269886
- ENSP00000269886
- ENSG00000141985
- ENST00000417295
- ENSP00000404568
- ENST00000598564
- ENSP00000470792
- CNSA1
- SH3D2B
- EEN
- CNSA1
- SH3P8
- SH3D2B
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
transcription factor binding site profile | 0.9 | ||
disease perturbation | 0.83 | ||
transcription factor | 0.74 | ||
kinase perturbation | 0.71 | ||
tissue sample | 0.69 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 58.6 (req: < 5)
Gene RIFs: 22 (req: <= 3)
Antibodies: 342 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 58.6 (req: >= 5)
Gene RIFs: 22 (req: > 3)
Antibodies: 342 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 14
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0